Versorgungswerk der Landesapothekerkammer Hessen
Partly autonomous pension scheme (teilrechtsfähige Einrichtung) of Landesapothekerkammer Hessen
Also known as Versorgungswerk der LAK Hessen, VWLAKH, Apothekerversorgungswerk Hessen
Pharmacists' pension scheme for Hessen; €2.23bn of investments (2025) incl. 16 infrastructure, 3 private-equity, 3 debt and 25 real-estate funds; €145M open fund commitments.
Pharmacists' pension scheme for Hessen, Frankfurt am Main. Not the Versorgungswerk der Rechtsanwälte im Lande Hessen or the Architekten- und Stadtplanerkammer Hessen's scheme (which belongs to the NRW architects' Versorgungswerk).
- HEADQUARTERS
- Frankfurt am Main, Germany
- FOUNDED
- —
- AUM
- €2.2B (2025)
- OUTSIDE CAPITAL
- No — own capital only
- TEAM LISTED
- 7 people
Focus
- STAGES
- —
- SECTORS
- —
- ASSET MIX
- Private equityPrivate creditReal estatePublic equities
- GEOGRAPHY
- —
Overview
The Versorgungswerk der Landesapothekerkammer Hessen is the compulsory pension scheme for pharmacists in Hessen, a partly autonomous institution of the Landesapothekerkammer Hessen with its own assets, supervised by the Hessian social affairs ministry. Its investments were €2,231.5M at end 2025. Besides its HSBC INKA securities master fund, it holds units in three debt funds, 25 real-estate funds, 16 infrastructure funds and three private-equity funds, and in 2025 set up a second master fund to pool alternative investments with a €100M medium-term commitment.
PORTFOLIO (7)
- YIELCO Infrastruktur IV SCS (feeder fund; 26% of units)
- VWLAKH Masterfonds AI (own master fund pooling alternative investments, launched 2025, €100M commitment)since 2025
- HI-Real Estate-Private Debt Fonds (real-estate debt fund; 25% of units)Real Estate & PropTech
- GRE-Debt-Fund (real-estate debt fund; 25% of units)Real Estate & PropTech
- Art-Invest HQT and SZT geschlossene Investment KGs (real-estate funds)Real Estate & PropTech
- HI-Immobilien Secondaries Fonds I and II, HI-Immobilien Asien Fonds II (real-estate funds)Real Estate & PropTech
- BNP Real Value Fund, Boston Capital Income and Value Fund, Euro Property I Fonds, Pan-Europa Fonds Nr. 3 (real-estate funds)Real Estate & PropTech
People
- Dr. Reinhard HoferichterChair of the Leitender Ausschuss (legal representative) · source
- Michael HeinzeDeputy Chair of the Leitender Ausschuss · source
- Michael AlandManaging Director (Geschäftsführer) · source
- Sascha DeubelDeputy Managing Director (stellv. Geschäftsführer, since 1 May 2025) · source
- Nurcan AlnouriMember of the Leitender Ausschuss · source
- Jochen SchmittMember of the Leitender Ausschuss · source
- Dr. Robin BrünnMember of the Leitender Ausschuss · source
Links
Frequently asked questions
Versorgungswerk der Landesapothekerkammer Hessen is a institutional investor based in Frankfurt am Main, Germany.
Versorgungswerk der Landesapothekerkammer Hessen does not primarily put its own money into private companies. It also commits capital to third-party funds as an LP.
Key people at Versorgungswerk der Landesapothekerkammer Hessen include Dr. Reinhard Hoferichter (Chair of the Leitender Ausschuss (legal representative)), Michael Heinze (Deputy Chair of the Leitender Ausschuss), Michael Aland (Managing Director (Geschäftsführer)) and Sascha Deubel (Deputy Managing Director (stellv. Geschäftsführer, since 1 May 2025)).
Versorgungswerk der Landesapothekerkammer Hessen's investments include YIELCO Infrastruktur IV SCS (feeder fund; 26% of units), VWLAKH Masterfonds AI (own master fund pooling alternative investments, launched 2025, €100M commitment), HI-Real Estate-Private Debt Fonds (real-estate debt fund; 25% of units), GRE-Debt-Fund (real-estate debt fund; 25% of units), Art-Invest HQT and SZT geschlossene Investment KGs (real-estate funds), HI-Immobilien Secondaries Fonds I and II, HI-Immobilien Asien Fonds II (real-estate funds) and BNP Real Value Fund, Boston Capital Income and Value Fund, Euro Property I Fonds, Pan-Europa Fonds Nr. 3 (real-estate funds).
No. Versorgungswerk der Landesapothekerkammer Hessen invests its own capital and does not raise money from outside investors.